⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

February 1, 2026Transplantation and Cellular Therapy

Early Outcomes of Pretransplant Immunosuppression (PTIS) Based Conditioning Regimen in Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

Khalil Ur Rahman Shahzad Sarwar Shahzad Nasir Safia Khan Asghar Ali Saba Tazeen Laila Bahadur Hina Peter Husnain Ali Summaira Naseeb Mehroze Fatima Syeda Aliah Asif Syed Kamran Mahmood Parvez Ahmed

View at Publisher

Ask AI

Bookmark

Share

Key Points

Patients undergoing hematopoietic stem cell transplantation experienced significant improvements post-pretransplant immunosuppression.
The use of a conditioning regimen resulted in enhanced early outcomes, particularly in thalassemia patients who underwent HSCT.
Assessment includes various health metrics to understand the impact of the pretransplant immunosuppression approach.
Observational analysis suggests a promising avenue for improving treatment for thalassemia through this stem cell transplantation technique.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Observational analysis evaluates early outcomes of pretransplant immunosuppression in thalassemia patients, highlighting its potential effectiveness.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rahman et al. (2026) studied this question.

synapsesocial.com/papers/69a7605bc6e9836116a2d078 https://doi.org/10.1016/j.jtct.2025.12.877

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Significance of CD34+ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD StatusTransplantation and Cellular Therapy · 2026
2Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary OutcomesTransplantation and Cellular Therapy · 2026
3Trends and Disparities in CAR-T Therapy Utilization, Inpatient Mortality, Length of Stay, and Costs in the United States (2017–2022)Transplantation and Cellular Therapy · 2026
4Cytomegalovirus After Autologous Hematopoietic Cell Transplantation: Impact on Outcome and A Personalized Risk-adapted Prevention StrategyTransplantation and Cellular Therapy · 2026
5Clinical trials in graft-versus-host disease: changes in study characteristics, investigated drugs, and endpoints over timeTransplantation and Cellular Therapy · 2026
6Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French ExperienceTransplantation and Cellular Therapy · 2026
7Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisTransplantation and Cellular Therapy · 2026
8Lung Complications after Allogeneic Hematopoietic Cell Transplant and Outcomes: Implications Beyond Bronchiolitis Obliterans SyndromeTransplantation and Cellular Therapy · 2026
9A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy · 2026
10Monospecific and Bispecific Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma: A Systematic Review, Meta-analysis and Meta-regressionTransplantation and Cellular Therapy · 2026

TMore from Transplantation and Cellular Therapy

More from Quaid-i-Azam University

More from Kidney Centre

More from Rawalpindi Medical University

More from Pakistan Institute of Medical Sciences

More from Pakistan Army

More from National Institute Of Blood Disease and Bone Marrow Transplantation